RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody combo shows promise for stubborn leukemia
Disease control OngoingThis study tests an experimental antibody called epcoritamab, given alone or with other drugs, in people with chronic lymphocytic leukemia (CLL) or Richter's syndrome that has come back or not responded to treatment. About 195 adults will receive the drug under the skin or by mou…
Matched conditions: RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 06:49 UTC
-
New Four-in-One antibody tackles tough leukemia
Disease control OngoingThis early-phase study tests a new drug called GNC-035 in people whose chronic lymphocytic leukemia (CLL) has come back or stopped responding to treatment. The drug is a tetra-specific antibody designed to attack cancer cells in multiple ways. The main goals are to check the drug…
Matched conditions: RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:40 UTC